Showing results (81-90 of 125) with videos related to
Sort By:
Pageof 13
American Heart Journal|September 26, 2007
C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) StudySohail Q Khan, Onkar Dhillon, Joachim Struck, et al.Respiration; International Review of Thoracic Diseases|July 20, 2010
Biomarkers and peak oxygen uptake in patients with chronic lung diseaseMicha T Maeder, Martin H Brutsche, Nisha Arenja, et al.Biological Psychiatry|April 12, 2005
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptideSylvia Brettschneider, Nils G Morgenthaler, Stefan J Teipel, et al.International Journal of Cardiology|January 31, 2012
Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery diseaseStephan von Haehling, Jana Papassotiriou, Nils G Morgenthaler, et al.Intensive Care Medicine|December 15, 2007
The influence of corticosteroids on the release of novel biomarkers in human endotoxemiaMartijn D de Kruif, Lucienne C Lemaire, Ida A Giebelen, et al.American Journal of Hypertension|July 17, 2010
Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertensionAmmar Habib, Malik A Al-Omari, Mahyar Khaleghi, et al.Swiss Medical Weekly|October 13, 2011
The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseasesNicole Nigro, Beat Müller, Nils G Morgenthaler, et al.The Journal of Clinical Endocrinology and Metabolism|November 25, 2011
Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer studyMartin Magnusson, Amra Jujic, Bo Hedblad, et al.Cerebrovascular Diseases (Basel, Switzerland)|February 1, 2014
The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic strokeMarlene Fischer, Mira Katan, Nils G Morgenthaler, et al.Journal of the American College of Cardiology|May 10, 2008
Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) studySohail Q Khan, Onkar Dhillon, Dominic Kelly, et al.Pageof 13